Clinical Trials Logo

Precancerous Condition clinical trials

View clinical trials related to Precancerous Condition.

Filter by:

NCT ID: NCT00769587 Completed - Clinical trials for Precancerous Condition

Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis

Start date: June 2007
Phase: Phase 2
Study type: Interventional

RATIONALE: Thalidomide may stop the growth of systemic mastocytosis by blocking blood flow to the disease. PURPOSE: This phase II trial is studying how well thalidomide works in treating patients with relapsed or progressive systemic mastocytosis.

NCT ID: NCT00740467 Recruiting - Lymphoma Clinical Trials

Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders

Start date: January 2008
Phase: Phase 2
Study type: Interventional

RATIONALE: Giving chemotherapy, such as fludarabine, busulfan, and cyclophosphamide, together with antithymocyte globulin before a donor stem cell transplant helps stop the growth of cancer and abnormal cells. Giving chemotherapy before or after transplant also stops the patient's immune system from rejecting the donor's stem cells. The donated stem cells may replace the patient's immune cells and help destroy any remaining cancer and abnormal cells (graft-versus-tumor effect). Sometimes the transplanted cells from a donor can also make an immune response against the body's normal cells. Giving cyclosporine and mycophenolate mofetil after the transplant may stop this from happening. PURPOSE: This phase II trial is studying how well stem cell transplant works in treating patients with hematological cancer or other disorders.

NCT ID: NCT00736216 Withdrawn - Cervical Cancer Clinical Trials

Knowledge and Perceptions About Human Papillomavirus and Cervical Cancer Risk Among Young Adults

Start date: July 2008
Phase: Phase 1
Study type: Observational

RATIONALE: Learning about young adults' knowledge and perceptions about risk factors for the human papilloma virus and cervical cancer may help doctors learn more about how to prevent human papilloma virus infection and cervical cancer in the future. PURPOSE: This clinical trial is studying knowledge and perceptions of the risk factors for human papilloma virus infection and cervical cancer in young adults.

NCT ID: NCT00733252 Withdrawn - Lung Cancer Clinical Trials

Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease

Start date: April 2008
Phase: Phase 1
Study type: Observational

RATIONALE: Diagnostic procedures, such as optical coherence tomography, may help find and diagnose lung cancer or precancerous cells. PURPOSE: This phase I trial is studying how well optical coherence tomography of the airway works in detecting abnormal cells in patients undergoing surgery for lung cancer or lung disease.

NCT ID: NCT00726830 Terminated - Pain Clinical Trials

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Start date: March 2009
Phase: N/A
Study type: Interventional

RATIONALE: Methadone, morphine, or oxycodone may help relieve pain caused by cancer. It is not yet known whether methadone is more effective than morphine or oxycodone in treating pain in patients with cancer. PURPOSE: This randomized clinical trial is studying methadone to see how well it works compared with morphine or oxycodone in treating pain in patients with cancer.

NCT ID: NCT00719563 Completed - Lymphoma Clinical Trials

American Ginseng in Treating Patients With Fatigue Caused by Cancer

Start date: October 2008
Phase: Phase 3
Study type: Interventional

RATIONALE: American ginseng may reduce fatigue in patients with cancer. It is not yet known whether American ginseng is more effective than a placebo in treating cancer-related fatigue. PURPOSE: This randomized phase III trial is studying American ginseng to see how well it works in treating patients with fatigue caused by cancer.

NCT ID: NCT00706121 Completed - Colorectal Cancer Clinical Trials

S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000

ACP
Start date: June 2008
Phase: Phase 3
Study type: Interventional

RATIONALE: Studying tissue samples in the laboratory from participants receiving treatment on the Selenium and Vitamin E Cancer Prevention Trial (SELECT) SWOG-S0000 may help doctors predict a participant's response to treatment and help plan the best treatment. PURPOSE: This phase III trial is studying the effect of vitamin E and/or selenium on colorectal polyps in men enrolled on SELECT Trial SWOG-S0000.

NCT ID: NCT00703196 Completed - Cervical Cancer Clinical Trials

Folic Acid Clinical Trial for the Prevention of Cervical Cancer

Start date: March 2007
Phase: Phase 2
Study type: Interventional

RATIONALE: Supplements, such as folic acid, may stop or delay the development of cervical cancer in women infected with human papillomavirus. PURPOSE: This phase II trial is studying how well folic acid supplements work in preventing cancer in women infected with human papillomavirus.

NCT ID: NCT00695422 Completed - Lymphoma Clinical Trials

Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials

Start date: May 14, 2008
Phase:
Study type: Observational

RATIONALE: Diagnostic procedures, such as anal swab collection, digital rectal examination, and anal endoscopy and biopsy, may help find and diagnose anal and genital human papillomavirus infection and squamous intraepithelial lesions and help doctors plan better treatment. PURPOSE: This clinical trial is studying ways to detect anal and genital human papillomavirus infection and squamous intraepithelial lesions in HIV-positive patients enrolled in an AIDS cancer clinical trial.

NCT ID: NCT00690924 Completed - Lung Cancer Clinical Trials

Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung Cancer

Start date: July 17, 2008
Phase: N/A
Study type: Interventional

RATIONALE: Calcitriol may prevent lung cancer in patients with metaplasia or dysplasia of the lungs. PURPOSE: This clinical trial is studying the side effects and best dose of calcitriol in preventing lung cancer in current smokers and former smokers at high risk of lung cancer.